Tudor Investment Corp ET AL Acquires New Shares in Globe Life Inc. $GL

Tudor Investment Corp ET AL acquired a new stake in shares of Globe Life Inc. (NYSE:GL) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 51,392 shares of the company’s stock, valued at approximately $7,348,000. Tudor Investment Corp ET AL owned 0.06% of Globe Life at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. CX Institutional boosted its position in Globe Life by 5.6% during the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after purchasing an additional 96 shares during the period. Laird Norton Wetherby Wealth Management LLC boosted its position in Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after purchasing an additional 99 shares during the period. KLP Kapitalforvaltning AS boosted its position in Globe Life by 0.5% during the 3rd quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company’s stock valued at $3,145,000 after purchasing an additional 100 shares during the period. Clearstead Advisors LLC boosted its position in Globe Life by 1.9% during the 3rd quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock valued at $754,000 after purchasing an additional 100 shares during the period. Finally, Journey Strategic Wealth LLC boosted its position in Globe Life by 5.0% during the 3rd quarter. Journey Strategic Wealth LLC now owns 2,103 shares of the company’s stock valued at $301,000 after purchasing an additional 101 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Insider Buying and Selling

In other news, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $147.91, for a total value of $258,842.50. Following the sale, the director owned 3,372 shares of the company’s stock, valued at approximately $498,752.52. The trade was a 34.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $143.14, for a total value of $1,431,400.00. Following the completion of the sale, the chief marketing officer directly owned 17,479 shares in the company, valued at $2,501,944.06. This represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 82,807 shares of company stock worth $12,041,286. 1.51% of the stock is owned by corporate insiders.

Globe Life Stock Up 0.1%

Shares of Globe Life stock opened at $143.52 on Wednesday. The business’s fifty day moving average price is $141.92 and its two-hundred day moving average price is $138.76. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $11.26 billion, a P/E ratio of 10.19 and a beta of 0.47. Globe Life Inc. has a 1-year low of $110.75 and a 1-year high of $152.71.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the firm earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, research analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be paid a $0.33 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. This is a boost from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s dividend payout ratio (DPR) is presently 9.38%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Texas Capital upgraded Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Truist Financial lifted their target price on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Piper Sandler raised Globe Life to a “strong-buy” rating in a research note on Thursday, April 2nd. Finally, Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and an average price target of $172.00.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.